lamivudine has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuczaj, A; Przybyłowski, P; Warwas, S; Zembala, M | 1 |
| Chen, YC; Chen, YS; Chi, NH; Chou, NK; Chuang, MK; Huang, SC; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, IH; Yu, HY | 1 |
2 other study(ies) available for lamivudine and Cardiac Failure
| Article | Year |
|---|---|
Heart Retransplantation From an Hepatitis B Core Antibody (Anti-HBcore)-Positive Donor: A Case Report.
Topics: Antiviral Agents; Graft Rejection; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Reoperation; Risk Factors; Tissue Donors | 2021 |
Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Donor Selection; Female; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Retrospective Studies; Taiwan; Time Factors; Treatment Outcome; Viral Load; Virus Activation; Young Adult | 2012 |